miDiagnostics

Leuven, Belgium

miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.

$31.5M raised

Dec 2024

Series D

Health Diagnostics

Top Investors

European Investment BankThermo Fisher ScientificAlychloPamica ABUrbain Vandeurzen

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about miDiagnostics

How much funding has miDiagnostics raised?

miDiagnostics has raised $31.5M in total funding. The most recent round was Series D. The last funding was announced in December 2024.

Who are miDiagnostics's investors?

miDiagnostics's investors include European Investment Bank, Thermo Fisher Scientific, Alychlo, Pamica AB, Urbain Vandeurzen.

Where is miDiagnostics headquartered?

miDiagnostics is headquartered in Leuven, Belgium.

What does miDiagnostics do?

miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.

What stage is miDiagnostics at?

miDiagnostics is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 4, 2024.

MLA

"miDiagnostics — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/midiagnostics. Accessed June 17, 2026.

APA

VCBacked. (2024). miDiagnostics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/midiagnostics

Wikipedia (cite web)

{{cite web |title=miDiagnostics — Funding & Investors |url=https://www.vcbacked.co/company/midiagnostics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 4, 2024.

Similar Companies in Health Diagnostics